<SEC-DOCUMENT>0001571049-14-004440.txt : 20140904
<SEC-HEADER>0001571049-14-004440.hdr.sgml : 20140904
<ACCEPTANCE-DATETIME>20140904160516
ACCESSION NUMBER:		0001571049-14-004440
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140828
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140904
DATE AS OF CHANGE:		20140904

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	002-90539
		FILM NUMBER:		141083277

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t80198_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Date of report (Date of earliest event reported):
August 28, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or Other Jurisdiction</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">of Incorporation)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>002-90539</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of Principal Executive Offices) (Zip
Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>631-240- 8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2 below):</P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"></TD>
    <TD STYLE="width: 95%"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 1.01&nbsp;&nbsp;Entry into a Material Definitive Agreement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On August 28, 2014, Applied DNA Sciences, Inc.
(the &ldquo;Company&rdquo;) was awarded a two &ndash;year development contract by the Office of the Secretary of Defense on behalf
of the Defense Logistic Agency (&ldquo;DLA&rdquo;) in the amount of $2.97 million. The Rapid Innovation Fund project will develop
a single authentication platform- the Company&rsquo;s &ldquo;Signature &reg; DNA&rdquo; and complementary technologies- to identify
authentic products and deter counterfeits from infiltrating six Department of Defense Federal Supply Groups (&ldquo;FSGs&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Those FSGs are, in order of risk to DLA:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1. &nbsp;FSG 59 (Electrical and Electronic Equipment Components)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2. &nbsp;FSG 31 (Bearings)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">3.&nbsp;&nbsp;FSG 25 (Vehicular Equipment Components)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">4.&nbsp; FSG 29 (Engine Accessories)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">5.&nbsp; FSG 47 (Pipe, Tubing, Hose, and Fittings)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">6. &nbsp;FSG 53 (Hardware and Abrasives)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company&rsquo;s DNA marking solution currently protects items
in DoD Federal Supply Class (FSC) 5962, Microcircuits.&nbsp; This project will demonstrate the Company&rsquo;s authentication solutions
for the other high-risk commodities above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company will perform services such as development, test and
evaluation, field trials, and transition to government operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 5.07.&nbsp;&nbsp;&nbsp;Submission of Matters to a Vote of Security
Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">On August 28, 2014 the
Company held its Annual Meeting of Stockholders. The following proposals were voted on and approved by the Company&rsquo;s stockholders
at the Annual Meeting with the stockholders having voted as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Proposal 1</I></B> - to elect our board
of directors, consisting of James A. Hayward, John Bitzer, III, Charles Ryan, Yacov Shamash, and Sanford R. Simon, each for a one-year
term or until their successors are duly elected and qualified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 1%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Directors</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Withheld</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">James A. Hayward</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">330,364,892</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">7,323,237</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">John Bitzer, III</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">333,767,295</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">3,920,834</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Charles Ryan</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">330,163,889</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">7,524,240</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Yacov Shamash</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">329,927,207</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">7,760,922</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Sanford R. Simon</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">330,001,919</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">7,686,210</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Broker Non-Votes:&nbsp;&nbsp;310,419,197</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Proposal 2</I></B> &ndash; Authorization
of Reverse Stock Split and Reduction in Authorized Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 28%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Abstain</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">585,212,821</FONT></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">59,250,452</FONT></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">3,744,053</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Broker Non-Votes:&nbsp;&nbsp;0</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Proposal 3</I></B>- to ratify the appointment of Marcum LLP
as our independent registered public accounting firm for the fiscal year ending September 30, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 28%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.1pt"></TD>
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Abstain</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in; text-align: center"><FONT STYLE="font-size: 10pt">624,338,059</FONT></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">4,134,226</P></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">19,735,041</P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in; text-align: center"></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in">
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD></TD>
    <TD STYLE="padding-right: 0.4in; padding-left: 0.4in">
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Broker Non-Votes:&nbsp;&nbsp;0</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 8.01&nbsp;&nbsp;Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A copy of the press release issued by the Company on August 28,
2014 relating to the contract awarded by the Office of the Secretary of Defense is furnished as Exhibit 99.1 and is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(d) Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">99.1 Press Release issued by Applied DNA Sciences,
Inc. on August 28, 2014.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Applied DNA Sciences, Inc.</B></FONT></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%"></TD>
    <TD STYLE="width: 4%"></TD>
    <TD STYLE="width: 34%"></TD>
    <TD STYLE="width: 11%"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: white 1pt solid"></TD>
    <TD COLSPAN="2" STYLE="border-bottom: white 1pt solid; text-decoration: underline"><FONT STYLE="font-size: 10pt"><U>By:&nbsp;/s/&nbsp;James A. Hayward</U></FONT></TD>
    <TD STYLE="border-bottom: white 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">James A. Hayward</FONT></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD>
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD>
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD>
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date:&nbsp;&nbsp;September 4, 2014</FONT></TD>
    <TD></TD>
    <TD></TD>
    <TD></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 16%"><U>Exhibit No.</U></TD>
    <TD STYLE="width: 84%"><U>Description</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>99.1</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Press Release issued by Applied
DNA Sciences, Inc. on August 28, 2014.</P>
</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="t79743001_v1.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; width: 50%; font-size: 10pt">PRESS RELEASE<BR> August 28, 2014</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: right">For Immediate Release<BR> Contact:<BR> Media Relations<BR> 631-240-8800<BR> Applied DNA Sciences</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="padding: 3pt">
        <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Office of Secretary of Defense Awards Applied
        DNA Sciences Competitive Development Contract on Behalf of DLA &nbsp; &nbsp;to Prevent Counterfeits in&nbsp;</B></P>
        <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Six High-Risk Federal Supply Groups</B></P>
        <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Contract Valued at $2.97 Million Over Two
        Years</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="padding: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4.5pt"><B>STONY BROOK, NY - August 28, 2014</B> --<B> Applied DNA
        Sciences, Inc.</B> (OTCQB: APDN),&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">a biotechnology firm that provides DNA-based authentication and
        security solutions and services, announced today that the company has been awarded a two-year development contract by the Office
        of the Secretary of Defense on behalf of the Defense Logistics Agency (DLA) in the amount of $2.97 million. &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Rapid Innovation Fund (RIF) project will develop a single authentication
        platform - APDN's &quot;SigNature&reg; DNA&quot; and complementary technologies - to identify authentic products and deter counterfeits
        from infiltrating six Department of Defense Federal Supply Groups (FSGs).</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Those FSGs are, in order of risk to DLA:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1. FSG 59 (Electrical and Electronic Equipment Components)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2. FSG 31 (Bearings)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">3. FSG 25 (Vehicular Equipment Components)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">4. FSG 29 (Engine Accessories)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">5. FSG 47 (Pipe, Tubing, Hose, and Fittings)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">6. FSG 53 (Hardware and Abrasives)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">APDN's DNA marking solution currently protects items in DoD Federal
        Supply Class (FSC) 5962, Microcircuits.&nbsp; This project will demonstrate APDN's authentication solutions for the other high-risk
        commodities above.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">APDN will perform services such as development, test and evaluation,
        field trials, and transition to government operations.&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>About Applied DNA Sciences</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">APDN is a provider of botanical-DNA based security and authentication
        solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments
        and consumers from theft, counterfeiting, fraud and diversion. SigNature&reg; DNA describes the uncopyable marker that is at the
        heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet&reg;,
        our anti-theft product, SigNature&reg; T, targeted toward textiles, and digitalDNA&reg;, providing powerful track and trace. All
        provide a forensic chain of evidence and can be used to prosecute perpetrators.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The statements made by APDN may be forward-looking in nature. Forward-looking
        statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number
        of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected
        due to our short operating history, limited financial resources, limited market acceptance, market competition and various other
        factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December
        20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December
        31, 2013) and Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information,
        events or circumstances after the date hereof to reflect the occurrence of unanticipated events.&nbsp;</P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #3366FF"><B>media contact</B></FONT> Mitchell
Miller, 631-240-8818</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #3366FF"><B>investor contact</B></FONT>&nbsp;
Debbie Bailey, 631-240-8817</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #3366FF"><B>web</B></FONT> www.adnas.com</P>

<P STYLE="margin: 0">twitter <FONT STYLE="font: 10pt Times New Roman, Times, Serif">@APDN, @APDNInvestor.&nbsp; &nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>t79743001_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 t79743001_v1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@`/@%>`P$1``(1`0,1`?_$`*4``0`"`@,!````````
M```````%!@$'`@,$"`$!``,!`0````````````````$#!`(%$``!`P0!`@,$
M!P8!!PT````!`@,$`!$%!A(A!S%!$U&!(A1A<9$R4A4(0F)R(S,6DJ'!@M)#
M8U>RPE.3L],D1#5U5A<W$0$``@(!`@,&!@(#`````````0(1`P0A$C%!(G&1
M4A-3!5%AH3)"(V)#@3,4_]H`#`,!``(1`Q$`/P#ZIH%`H%`H%`H%`H%`H%`H
M%`O43(5(4"@4"@4"@4"@4"@4"@4"@4"@4"]!X\GF<3BHBIF3EM0HJ/O//K2V
MG[5$4&I=J_4[IN.*V<''>S,A-P'1_(C7'[ZQR5[DT&NX_P"H/NOGL_%:PT9@
M(4\@?EL9@O<TJ4`4K6JZO#S%J#ZH:*BVDK'%9`*D^-B?$4'*@4"@4"@4"@4"
M@4"@4$7L6S8'7(`R&;FH@PBL-!]V_'FJ]D]`?&U!(1I#,F.U(86'&7D)<:6/
M!2%BZ2/K!H.R@4"@\V3R4+&8^1D)SPCPXJ"[(>5>R$)ZE1M0=.#SN)SN-:R>
M)E(F0'K^E(;OQ5Q)2;7`/0B@]KB@E!4>@'4GZ!0G'FC,)LN#SK3KV)EHF-L+
M])Y2+_"NU[=0*[OJO3I,*]>RM_!*UPL*!0*!0*!0*!0*!0*!0*!0*!0=<F0S
M'86^\XEIEH%;CBU!*4I'4DJ/0`"@T)W$_4W'CK=Q^F-)D.))2O,/C^4#_N6_
M%?\`$KI]%!H//['GL_-5+S<]Z?)OXOJ)";^2$>"1]0H-I]KM?[!RRR<YE7I&
M4Z7B9$&''Y>:4\"4K%_Q+]U!O-S%/8]V&C4XS$;$<`;04-!"E>7,I'4>'B?"
M@N@\!09H%`H%`H%!$9_;M9UYE#V;R3&/;<_I^LL)*OX4_>/N%!RP.U:[L$=4
MC"9!C(-(-EEA844G]Y/B/>*#U9/,8O%0US<E*:AQ&_OOOK2V@>]1%!%8'N!I
M>P2%1L-F8TV2GJ66UCG8>82;$CZJ";D2H\9A<B0XEIAH%3CJU!*4@>))-@*"
MNXWN;V_R>0&/@9Z'(FDV2RET74?8DFP5[C04;]4AOVT1_P"X,?\`)70<>XV%
MBY/4]+$C:QK*61'*>14D/J+*.B>!2>:;?#?IUH-K2I\+&0%2I\I#,5E`+LI]
M:4)``\5*-AUH(C"=QM&SDPPL3FXDN7Y,(<`6?X0JW+W4$[)FQ8L=<F4ZAB.T
M.3KSB@A"0/-2C8"@UOO_`'$T?.:%L^/Q.;B2YHQ[]HZ'!R5\)^Z#;E[J#M_3
M\H)[38=1-DI^8))L`!ZZ_&HQF29PLCG<#2G)+F/1FHBI=E)],.#JJQZ<ONW]
M]:(XNS'=CHHMR-?AE1_T\?\`HF:Z?^>_YE>A]XCUUC_%A^U_MM/^2^3-^TR%
M/_+Y68BM3`>*FE.#X5>Q1\$^\UYU>->U>Z(Z-\[Z1.)E.H<0M`6@A2%=4J!!
M!!\""*I6Y0.0W_3($TPIF8BLR@;*:*P2D^Q1%PGWU;7B[9C,1T4VY.N)Q,]4
MZQ(8D-)>8<2ZTL`H<00I*@?,$=#56)CI*Z+1*LSNZ_;F#D58Z7L$1J8A7!;9
M7<)5X64H`I!]]$K*[-BLQC*==0W&2GFI]:@E`1:_(J)M:@@H>\Z;G)#^+Q.<
MC29_I.**([B5K0E(LI8MT^&]!5.Q^&BXO%Y9,?:1M"79G)3J%*4EE03]T\BH
M\U>*K=*"U9GN3HF%F_(Y7.1(DP6Y,+<!6F_X@F_'WT$[#GPIT9N5#?;DQ71R
M:?:4%H4/H4.E!"9KN)H^#FI@Y?-18<PV_D..#F.7AR`OQ]]!.19L67&:DQ74
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MU],_3QW#6M2XV-2VDDD-*?;4D#V7*KFN=^GC_P`;+=6[=YTAX_[3[WZ"!+BL
M9"%'3U4N&OYAD?QMH*T_:FL%OREKKF?&$WCOU/;]':2Q.C0I*T]%/EM:'"1^
M)*5!-_=76J*S/JZ0YW1?'I7K5NZG=':8QD8*#BIB4_U&@YP=0?WVE.!8^RMT
M:>-/\Y]S#W\GX4[^>]_/_C^/_P"L'_>UU_Y^+\<^X^9R?AAZ,=F>]Z\A'1.P
M,!$-3B4R5AP`I;)^)0LXKP'T57;3QXK,Q><^QUKV<B9ZUALE)^NO/C#=ASJ4
ME!\X]N]6QO=#>]HS^W%4QO'2?EHF-4M24H05+"`>)!"4I1:P\3>]!V[1K6.[
M9=V=4FZNI42'G'OEIN.YE2.!6EM0L224GU+B_@1TH/7OL!.]]]X>G922M&!Q
MD4251$**?57Z?JJ]ZK@7\@.E!T]ZNU^M:?KT?;M40K#Y/&2&0CTG%E*^:N(/
MQ$D*!Z_2/&@QW7SN3VQOMYK;KZH,39T,R<F4_""7."0#]`NH@'I>U!,=Q>Q.
M@0=%GS,1&5C\CBHZI+,P.K*EJ9%[.<C8\O:+6/A05#==BR.P?IKP\[(K+TM$
M]N.M]753@9+B`M7TD#K03'?L`Z3V^O\`]-'_`.P;H(_]16<DS-WPFMR6Y,G"
M,,M2W\?#_JR%N*4#QZ'J$HL/9UH*AM"->G08_P#:FB9G`YR,M"XTUOUG`>)_
M;!!5?S"AYT%W[FS-CV7)=O=*SCB\>,NPP_FDCH5/K/`A7E<!!('XC03G<_L7
MV^Q^A9#(XF)^7S\3'5(:D^HM?J>F+E+@42#S'3IYT%;:S&1@?I^UJ%&<+`RT
MAYE]T$I/I>JX2FX\E'Q^BO3^U::WV3,QGMC+SON6R:TB(\Y;'5V.T1.MF*6#
M\X&>7YF%JY\PF_.U^'&_E:N9^Z;9O^6?#!'V_7%/S_%4>V$V7C.UNX3(Z^+\
M=:_2='X@T$\A]MZW?<*_,Y-(GS9>%?MTWQY._2>V.KY;MB[EYS!=RLIN0^F8
M5JY-EHJX@"]C]SK?QKCD\Z^O=V5G%<^&'7'X=+:N^?W8_%T:_MN8@]AI\AMY
M1D1Y!@QWR3R0VZI/@?W>9`KK=QZ6Y<1CIC+G3NM7C3,^.5BTCL]I<O48<G)1
MS-FY%E+[LKU%`I+@O9NQ`^'Z??6?E?<MM-DQ7I6OEB%^C@:[TBUNLSYHSM<,
MJPYN>E19JEB"EU.,D$_TUKYM@BWW1?B>GG4_<ZQ:E-F,38X%YB]J>4-9ZXYJ
M6H1W<!W+TAY3SCR_4S9"BOB?-)^&X'B"VKK7D/47KO9.5L&?TC28$XQ]?S0:
M>6^@]'$+4$-'K][B@&U_,T&Q]9[2Z)J3JIV%@%J>B.XP92W7%K4E0^*X4KCU
MX^0H-/=I\[,P/9_?<M`/&9&DJ+"OPK6A*`K_`$>5Z"G::_J",.M_.Z7EMFR,
MQ2W'<FA;H:ZFW\O@/O>TGSH-B=A'=EQ2MK0UCYT+5VXZY>-;R*5)4V^`2$`D
M)!/#[W$>5!Y>R';/5]WUK+9_:&5Y#)3IKK7KJ<6"@\$J*T\2/B*E^?L`H./:
M/9\OK_;??VH[BG1KRUJQ@7U]-2@M!('L"D!=J"1[/=F]/V74V]GV9#F7R.5<
M=6LN/+`0`LILK@4E2SQN;F@KW?#)I?[EX_6I425-UO"1F"WAX1(<=NBYMT5^
MR`GEXVO05W8QC9;D&3I&D9G7LY#=0MIY"7G4*L>EP4D\KVZW^N@O_>7!;2]F
MM6VO)8)S/8J'";&5Q#?(AN01R="DHY$`D_>L1TL:"V]E=A[:Y:1DU:KB58+*
ME#?YGCE`INE)(0M(!*>A40;`'VT$/W_[09'9%-[-@6_7RD=H,S8'[3[2;E*F
M_P!]-ST\Q1.6CM=V^="F)Q^>R.48A,_RE_+.J#[)3T`])Q0Z#\/C6W3S>R,3
M6MO:Q;N)%YSW6CV-FQ7.W$EL+;[BY4W%RDH>"A?R(\J]#7OO?]NJC%?36GCL
ML[?2[=W_`/T7*7_@>J[&[Z5/T48U?4NR$=O`;_\`V-E!_HO4_NC_`$U_1/\`
M5]6R'G:?V7F.*=?W&4IY?53WRQY$^TGCU]]4;M.W9'_5$+=6W72<_,EKS/XA
MO6\G\QK>=^?C?[*;'#L9Y`/[+J?A_P`AM7G7XFW7'=->D>QZ%.7JV>F+=?<N
M&AY_!Y:,\WLNUY3$3V3=LMJ<=:=0?,6)(4#X@ULT<N=DXKKK/N9>1Q:Z^LWM
M$+3Z?;O_`(BY3_`]6O&[Z5?T9.[3]2R9U//=N=?S"<B=XGY`)0I'RSZ'?2/(
M6NH6-[>54[]._9&/EQ'L6ZMVFDY[YEL[7>Y.G;#/5`Q.13(EA!<]+@M)XI\3
M\0'MKR]W$V:XS:'HZ>9KV3BLK/?Z:S-+2VT=H]XQ.VR]J[;Y-N&_DB53\>^0
M$%:C=5N04A22KXK'P/A4B!>[-]W<KM6%V78LE%GRXTIER2SS*0PPRXE?%L)2
M$&_4V`]]!';Q@,_G/U#S8FOSQC<RS%:DPY1N`%M,)/$D7MR'3P-!/J[3=V=T
MR$-'<7,,C"0EA9AQ>)4Z1T\$)2D$_B/N%!'_`*@<$J?O^D8*`Z(*WVOEHCPO
M9H^LE+9`%C\-AX4'MG=M>_FRL)U_8]AC(P`(#\EHA3CR$GIR2E"5+/3P40/;
M06GN/VFE3NU\#3=50VDP7F5H,A?`*2@*YK4H`_$I2[^%!U=TNVNR[-K>J8[&
M>A\QAG&E3/5<X)LAI*%<#8WZIH)'NIVJ=VX0,MB)IQFSXFWR4SJ$J2#RX**>
MHLKJE7^:@J*.W7?79I4:)MVQI@X>,H*<,!P)>=L?+TDM]2/-1Z>R@N/<[M'%
MVS"X]K'RCC\SA0/RJ<HJ40$V^!Q7W_%(/+Q!ZT%&E]M>_&U,MX/:\_'9P*5#
MYAQ@I4XZE)Z7"$)*SYCD;>V@V;F.V6"GZ/'U-J\>+!0@0'A\2VUMCHLW\>5S
MR^NK^/R)U7S"CDZ(VUQ*B_V1WM$+^WSF6/R@I#/S7/\`F>E:Q%^/JVMY7]]>
ME')XN>_MGN>?_P"?D=O;W=%O';M.+[:SM6Q*@[+E,K"I#OP!QY=KJ5:_$=.E
M8XYDVWQLMX0U1QNW5-(\9>S2]9RF([>-8&8&_GT,/MG@KDCDZ5E/Q6'XJKY6
MZM]W?'AEWQ]5JZNV?%#:'VTE0M!GZQL26R)SSBE>BKEQ2I*0E0-A\25)O6CE
M<R+;8O7R5<;BS75-+>:OQ-$[S8)E6$PF:87AR2&7W"`MI"CUXA25*2?H%7WY
M/'V>JU9[F>NC?2.VL^E(=N^VFUZS,V%R1)94[/BEF#-0LE1>NI0<6DBX^)5_
M.JN?SJ[HK$1CM7\+BVUS,VZY5G-:/^H7:,8G6-AE8U6(6X@OY$<"X0V00;)2
M%7\^@%>8]!<][[+0=AU7#XV!+5"RNOM(;Q>05<DAM('%SCU`44A5QU!H.C0,
M%WL@Y<M;;EHV0PB8SK:."DJ=+IL&U*/IH5X7ZWH.OM)VMR>!U?8,'M#;+K.9
MD+46V7/4!96WP-S9-C05J-VQ[WZ>I_%:5G6'\`ZM2F$2BD.,A1Z_"M"^*O:4
M=#XVH+OHO;3,:_KF73E<N[F,_EV7$NO.N.*9;*D*"4-A9-AR5=2K4'+LCI&;
MTO3W<3FO2^;7,<D#T%EQ/!:4)'4A/7X:"+[5]KLM@FMMB;&TP]"V!\E#32RO
MDRKU`H+Z)XFRZ"LQNTO>33WY,71-A8.%>67&H\H@*03TZI6AQ/+VE-KT%I[B
M=I<SL*L3LF'R*<;NV,9;0N4"0V\I*;FY`/$A158VM8V(H(&+VW[T[/DHG][[
M$(>(B*"EQ\>YZ;CUO$79#8'+P)4?J%!:M^@=X&<Q$EZ)*BG&(C!F1CIA3;U$
MDV6"L?AL/O4'D[3]MMFP^?S&W;6^PO/9@<%1HMO2;3R"E$D`"YXCPH-ID4%(
MWSM!IVYH+N0C?+9("S>2C60\/9SZ66/H51/=+0&V_ITWW!.*DX>V;AH^)*XQ
M].0!X]6B>I_A)KJM[5\)F'-JUGQA#XGNCL^MN_)9C"P)Y:^'T,G"2V^+=/OI
M2VK[;U9&^WQ6]ZN=-?PA8X_?G'N$)<U##,KO8E31X_;6O3LI;QO>/^67=JO'
MA2LKEBL[M.6CB3BM%P<Y@_[1@M.`?7Q7TK3/RH_VV9H^;].JM;SW'F81F1B<
MEJ&&B9"2RML(;2E;K0<24\R$%7$B]Q>L^^:=O39:R_3&R;=:5A4>S^M[6[E3
MG\3@$9J'$"V%MR0GT%..)MYD<BD&_3PK/Q8KG-K=K3RYM_&.YN'EW!_X;XK_
M``(_UJW_`-/U;,']OTZG+N#_`,-\5_@1_K5.=/U;&=WTZO1"R?="`XIV#H&/
MBNJ'%3C(2A1'LNE8Z57>FBT>K9:7==F^)Z:ZI5C;>\:F9!=U*.E;;84P/5(Y
M+YI!3;GU^`J/NJN>/QNGKG#N-_(^"&S>(]E>:]%FPH-71]`V1'?9_<E--?D;
MD/T$N>I_-Y^B$?T[>'(4&T`.G7QH-8=P]!V3.]R=0S^/;:5CL,L*G+<<"%@!
MT+^!-OBZ"@V?8>R@S0+"@6%`L+WMUH!%Z!84"@XVZ^%1T.K-A[/"IPC)QJ.B
M>I:I"P]E1@B2P\+4&;"I"@QQ'LH,V%`L*!0+"@6%`L*!:@6%!CB*#-A0*!0+
M"@B\]K^N9>(MO-P8TR.!\7S*$*"1_$K[ON-!\U]T=6[#XWU?R;+O,95-[0(!
M$UGE[%<B`@7_`-Y[JF9/!J7#OYAB<V,,Y(;GK-FDPRL.J)]@;ZU"<MQZ!^F_
M/YA]&3W-QR!#</J+AA7*8]?J?47U]._GXJ^JHZ&9?2.(PV,P^.CXW&1D1849
M(0RPV+)`'^<^9J90]MJC`6I@+4"PH,U(4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4'%R_$V^]8VOX7H/DW.Z?WZW'.RXN2CS5MH>6FSS
MGH04IY'CPZ\5)MX6!H+=JGZ5$#@]M&5Y#Q5"@)XCZB\L7^Q-!N;5M!U'5F/2
MP>-:B*(^-^W-Y7\3BKJ/VT%@`M0*!0*!0*!0*!4!0*D*!0*!0*!0*@<%J<'W
M47]XKH=?_BR?(#W4'*TCV@T"\CV`U`SR>_`/MH'-W\'^44'(*7^`_:*#()/B
E+4&:!0*!0*!0*!0*!0*!0*!0#:@=+=?"@=*!0*!0*!0*!0?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
